ATE141105T1 - T-zell lymphoma cdna klone - Google Patents

T-zell lymphoma cdna klone

Info

Publication number
ATE141105T1
ATE141105T1 AT91908417T AT91908417T ATE141105T1 AT E141105 T1 ATE141105 T1 AT E141105T1 AT 91908417 T AT91908417 T AT 91908417T AT 91908417 T AT91908417 T AT 91908417T AT E141105 T1 ATE141105 T1 AT E141105T1
Authority
AT
Austria
Prior art keywords
novel
expressed
proteins
cell
dna sequences
Prior art date
Application number
AT91908417T
Other languages
English (en)
Inventor
Carol L Macleod
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Application granted granted Critical
Publication of ATE141105T1 publication Critical patent/ATE141105T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT91908417T 1990-04-13 1991-04-12 T-zell lymphoma cdna klone ATE141105T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50968490A 1990-04-13 1990-04-13

Publications (1)

Publication Number Publication Date
ATE141105T1 true ATE141105T1 (de) 1996-08-15

Family

ID=24027673

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91908417T ATE141105T1 (de) 1990-04-13 1991-04-12 T-zell lymphoma cdna klone

Country Status (22)

Country Link
US (2) US5312733A (de)
EP (1) EP0527813B1 (de)
JP (1) JPH05506989A (de)
KR (1) KR100212371B1 (de)
AT (1) ATE141105T1 (de)
AU (1) AU664535B2 (de)
CA (1) CA2080018C (de)
DE (1) DE69121240T2 (de)
DK (1) DK0527813T3 (de)
ES (1) ES2093100T3 (de)
FI (1) FI108037B (de)
GR (1) GR3021478T3 (de)
HK (1) HK1006726A1 (de)
IE (1) IE75903B1 (de)
IL (1) IL97775A (de)
NO (1) NO307341B1 (de)
NZ (1) NZ237669A (de)
PT (1) PT97355B (de)
RU (1) RU2116346C1 (de)
SA (1) SA92120348B1 (de)
WO (1) WO1991016430A1 (de)
ZA (1) ZA912489B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6784163B1 (en) * 1990-04-13 2004-08-31 Macleod Carol L. Inhibition of cationic amino acid transporter protein and uses thereof
WO1994004567A1 (en) * 1992-08-21 1994-03-03 La Jolla Cancer Research Foundation A matrix-associating dna-protein, nucleic acids encoding the same and methods for detecting the nucleic acids
WO1994026290A1 (en) * 1993-05-07 1994-11-24 Immunex Corporation Cytokine designated 4-1bb ligand and human receptor that binds thereto
US7138500B1 (en) 1993-05-07 2006-11-21 Immunex Corporation Antibodies to human 4-1BB
US7211259B1 (en) 1993-05-07 2007-05-01 Immunex Corporation 4-1BB polypeptides and DNA encoding 4-1BB polypeptides
US5866329A (en) * 1995-09-27 1999-02-02 Demetriou; Achilles A. Method and probe for detection of gene associated with liver neoplastic disease
US5861248A (en) * 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
US6627199B1 (en) * 1999-07-09 2003-09-30 Amgen Inc Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
US20030096355A1 (en) * 1999-07-09 2003-05-22 Ke Zhang Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family
AU6517800A (en) * 1999-08-04 2001-03-05 Amgen, Inc. Ntr3, a member of the tnf-receptor supergene family
US6521422B1 (en) * 1999-08-04 2003-02-18 Amgen Inc. Fhm, a novel member of the TNF ligand supergene family
AU2002364889A1 (en) * 2001-09-24 2003-06-10 University Of Aarhus Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
EP1913401A4 (de) * 2005-08-03 2009-11-18 Astrazeneca Ab Verfahren zur identifizierung eines den arginintransport in einem chondrozyten modulierenden agens
CA2629532C (en) 2005-11-18 2016-08-09 University Health Network Method of expanding double negative t cells
AU2010258094B2 (en) 2009-06-10 2013-09-05 Stephen Sanig Research Institute Ltd. Methods of generating cells exhibiting phenotypic plasticity

Also Published As

Publication number Publication date
JPH05506989A (ja) 1993-10-14
RU2116346C1 (ru) 1998-07-27
FI108037B (fi) 2001-11-15
CA2080018C (en) 2003-10-14
PT97355A (pt) 1991-12-31
IL97775A0 (en) 1992-06-21
KR100212371B1 (ko) 1999-08-02
HK1006726A1 (en) 1999-03-12
AU7745791A (en) 1991-11-11
CA2080018A1 (en) 1991-10-14
US5440017A (en) 1995-08-08
EP0527813A1 (de) 1993-02-24
NO307341B1 (no) 2000-03-20
PT97355B (pt) 1998-08-31
EP0527813A4 (en) 1993-05-05
FI924575A0 (fi) 1992-10-09
US5312733A (en) 1994-05-17
DE69121240T2 (de) 1997-01-09
IE911250A1 (en) 1991-10-23
NO923918L (no) 1992-12-01
NO923918D0 (no) 1992-10-08
ES2093100T3 (es) 1996-12-16
ZA912489B (en) 1992-01-29
IE75903B1 (en) 1997-10-08
GR3021478T3 (en) 1997-01-31
AU664535B2 (en) 1995-11-23
FI924575A (fi) 1992-10-09
IL97775A (en) 1998-04-05
EP0527813B1 (de) 1996-08-07
NZ237669A (en) 1992-08-26
DE69121240D1 (de) 1996-09-12
DK0527813T3 (da) 1996-12-30
SA92120348B1 (ar) 2004-01-24
KR930700657A (ko) 1993-03-15
WO1991016430A1 (en) 1991-10-31

Similar Documents

Publication Publication Date Title
ATE141105T1 (de) T-zell lymphoma cdna klone
DE69535375D1 (de) Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper
EP0590071A4 (en) Substantially pure receptor like tgf--g(b)1 binding molecules and uses thereof
UA40621C2 (uk) Моноклональне антитіло, гібридомна клітинна лінія, поліпептид (варіанти), фрагмент днк (варіанти), фармацевтична композиція, спосіб одержання моноклонального антитіла
DK368588D0 (da) Bindingsmolekyler med en enkelt plypeptidkaede
DK0528932T3 (da) Protein associeret med akut pancreatitis og midler til diagnose af akut pancreatitis
Young et al. The amino acid sequences of jacalin and the Maclura pomifera agglutinin
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
ATE362941T1 (de) Identifikation, reinigung und verwendungen von leczymen und karbohydratliganden
DE69535855D1 (de) Calciumbindende rekombinante antikörper gegen protein c
ATE303437T1 (de) Rezeptor des ob-proteins und verwandte zusammensetzungen und verfahren
ATE212056T1 (de) Methoden zur herstellung von rna viren aus cdna
DE69233155D1 (de) Insulinartigen wachstumsfaktor bindendes protein
ATE190491T1 (de) Peptide als diagnose- und therapiemittel für spondyloarthropathien
ATE281519T1 (de) Klonierung und rekombinante herstellung des crf- rezeptors (crf=corticotropin ausloese faktor)
MacLeod T-cell lymphoma CDNA clones
RU97106012A (ru) Новые связывающие рка белки и их использование

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee